Abfero Pharmaceuticals
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
405 Waltham St Ste 353, Lexington, Massa...Phone Number
(781) 266-7297Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Abfero Pharmaceuticals
Abfero Pharmaceuticals is a clinical stage pharmaceutical company dedicated to developing safe and effective oral iron chelators for the treatment of diseases related to iron overload. Their lead candidate, SP-420, targets systemic and local iron overload, addressing conditions that can lead to severe organ damage and vision loss. The company focuses on patients suffering from transfusional iron overload and age-related macular degeneration, aiming to provide innovative therapies for these growing health concerns. Recently acquired by Pharmacosmos, Abfero is positioned to expand its impact in the field of iron-related disorders.Explore more
Abfero Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Abfero Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Abfero Pharmaceuticals recently announced quarterly report
Abfero Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Abfero Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Check if Abfero Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Abfero Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Abfero Pharmaceuticals
Funding: Get notified immidiatlly once Abfero Pharmaceuticals has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Abfero Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Abfero Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Abfero Pharmaceuticals
Compare insights from companies similar to Abfero Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Abfero Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Abfero Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abfero Pharmaceuticals.
Abfero Pharmaceuticals financials insights
Gather financial insights about Abfero Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Unspecified
$2.4M
Abfero Pharmaceuticals Tech Stack
A closer look at the technologies used by Abfero Pharmaceuticals
Abfero Pharmaceuticals News & Media
AbFero Pharmaceuticals Announces Funding From Cure Parkinson's For Lead Compound SP-420
HARWELL, England, Feb. 17, 2021 /PRNewswire/ -- AbFero Ltd., a subsidiary of AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload, today announced the award of a grant from Cure Parkinson's for the development...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abfero Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Abfero Pharmaceuticals is a clinical stage pharmaceutical company dedicated to developing safe and effective oral iron chelators for the treatment of diseases related to iron overload. Their lead candidate, SP-420, targets systemic and local iron overload, addressing conditions that can lead to severe organ damage and vision loss. The company focus... Read More
